Skip to content

Frontiers in Psychiatry

ISSN 1664-0640

601 papers in the library · 9,228 citations · publishing 2010-2026

Papers

Sort Most recent Most cited

High hopes? Precision psychedelic addiction medicine.

Frontiers in Psychiatry 2025 Rayyan Raja Zafar, Patrick Kleine, Danielle Kurtin et al.

Despite decades of neuroscience research and significant investment in addiction neuroimaging, clinical outcomes for individuals with substance use and behavioural addictions remain poor. Only 1.8% of people with substance use disorders receive effective treatment, highlighting a major disconnect between mechanistic understanding and clinical utility. This paper calls for a reorientation of...

Novel and emerging anesthetic drugs for the treatments of major depression: a comprehensive review of efficacy, mechanism, and outlook.

Frontiers in Psychiatry 2025 Congyi Li, Zhihui Wang, Xinman Ye et al.

Clinical and preclinical studies increasingly support the antidepressant potential of several anesthetic agents, including ketamine, propofol, nitrous oxide (N2O), sevoflurane, and isoflurane. Their therapeutic effects appear to arise from the regulation of multiple interconnected systems: modulation of glutamatergic and GABAergic signaling, interaction with monoaminergic neurotransmitters...

Analysis of self-transcendence status and influencing factors in gastric cancer patients undergoing chemotherapy: a random forest model-based study.

Frontiers in Psychiatry 2025 Qin Wang, Guoqin Ren, Li Sun et al.

To investigate the current status and determinants of self-transcendence in gastric cancer patients undergoing chemotherapy and to establish a foundation for clinical development of interventions. A convenience sampling method was employed to select 507 gastric cancer patients undergoing chemotherapy in the oncology department of a tertiary hospital in Wuxi City, Jiangsu Province, from October...

DOI: 10.3389/fpsyt.2025.1641453 (opens in new tab) Full text (opens in new tab) Artificial intelligence Chemotherapy Gastric cancer Influencing factors +2

The impact of mindfulness training on emotional resilience and job engagement among NICU and PICU Saudi and Egyptian nurses: a quasi experimental comparative study.

Frontiers in Psychiatry 2025 Amal I Khalil, Abeer Esawi, Ebtesam Abdulshakoor et al.

Nurses working in Neonatal and Pediatric Intensive Care Units (NICU/PICU) experience high levels of stress that can diminish emotional resilience and job engagement. Mindfulness-based interventions (MBIs) are known to enhance psychological well-being; however, evidence in culturally diverse settings, such as Saudi Arabia and Egypt, remains limited. This study assessed the effects of mindfulness...

Painting psychosis: an empirical investigation of the self-portraits of Edvard Munch.

Frontiers in Psychiatry 2025 Eric C Bettelheim, Jingyi Liu, Paola Dazzan et al.

Substantial evidence demonstrates that the brain is more interested in faces than in other subjects and that self-related material, particularly self-images, have higher saliency than non-self-referential material. Studies of self-portraits have revealed correlations between stylistic elements and artists' states of mind. Edvard Munch, a founder of Expressionism and most famous for "The...

DOI: 10.3389/fpsyt.2025.1643264 (opens in new tab) Full text (opens in new tab) Edvard munch Neuroscience of art Painting Psychosis +4

The effects of short video app-guided mindfulness meditation on rumination, self-compassion, psychological flexibility, and depression among individuals experiencing entrepreneurial failure.

Frontiers in Psychiatry 2025 Ye-Hui Tu, Chao Liu, Zheng-Hao Gao et al.

This study aimed to evaluate the effectiveness of a short video app-guided mindfulness meditation intervention in improving psychological flexibility and self-compassion and reducing rumination and depressive symptoms among failed entrepreneurs. A randomized controlled trial was conducted with 100 recently failed entrepreneurs (aged 25-55), who were randomly assigned to either an intervention...

DOI: 10.3389/fpsyt.2025.1706661 (opens in new tab) Full text (opens in new tab) Depression Mindfulness meditation Psychological flexibility Rumination +1

Nitrous oxide use and psychiatric disorders: a retrospective clinical cohort study on prevalence and patterns.

Frontiers in Psychiatry 2025 Rebecca Paetow, Maike Franziska Dohrn, Michelle Finner-Prével et al.

Nitrous oxide (N2O) is used for anesthetic purposes but has gained popularity as a recreational substance. Despite its potentially severe adverse effects, knowledge about N2O use within psychiatric populations is limited. This study aimed to evaluate the life-time prevalence and patterns of N2O consumption among patients with psychiatric disorders. A retrospective observational cohort study was...

DOI: 10.3389/fpsyt.2025.1670500 (opens in new tab) Full text (opens in new tab) Depression ADHD Cannabis-related disorders Lifetime prevalence +4

The impact of illness perception on self-transcendence in gastric cancer patients undergoing chemotherapy: the chain mediating effect of hope levels and coping styles.

Frontiers in Psychiatry 2025 Qin Wang, Guoqin Ren, Li Sun et al.

To investigate the current status of illness perception, hope levels, coping styles, and self-transcendence among gastric cancer patients undergoing chemotherapy, and to explore the chain-mediating role of hope levels and coping styles in illness perception and self-transcendence. This study is a cross-sectional study. A convenience sampling method was used to select 507 gastric cancer patients...

DOI: 10.3389/fpsyt.2025.1679697 (opens in new tab) Full text (opens in new tab) Chemotherapy patients Coping styles Gastric cancer Hope levels +4

The efficacy of meditation on insula dysfunction in patients with chronic schizophrenia.

Frontiers in Psychiatry 2025 Di Kong, Shoukang Zou, Yanqing Huang et al.

Meditation combined with antipsychotic medication can effectively improve the clinical symptoms and prognosis of patients with schizophrenia, but its underlying neural circuit mechanism is not clear. Many previous studies have shown that the symptoms of schizophrenia are related to dysfunction of the insula. We aimed to explore the neural circuitry mechanisms associated with insular dynamic...

Effects of mindfulness-based interventions on insight and stigma in patients with schizophrenia: a systematic review and meta-analysis.

Frontiers in Psychiatry 2025 Xiaoxin Gao, Lixiu Wu, Guolin Jin et al.

To systematically evaluate the impact of mindfulness-based interventions on insight and stigma in patients with schizophrenia. Randomized controlled trials (RCTs) and quasi-randomized controlled trials investigating the effects of mindfulness-based interventions on insight and stigma in schizophrenia patients were retrieved from databases including CNKI, Wanfang, VIP, CBM, PubMed, Cochrane...

DOI: 10.3389/fpsyt.2025.1655057 (opens in new tab) Full text (opens in new tab) Insight Meta-analysis Mindfulness-based intervention Schizophrenia +1

Effectiveness of pranayama for mental disorders: a systematic review and meta-analysis of randomized controlled trials.

Frontiers in Psychiatry 2025 Christian Mütze, Dietmar Mitzinger, Heidemarie Haller

This review systematically assessed the evidence on the effectiveness and safety of prāṇāyāma, traditional yogic breathing techniques, for patients diagnosed with mental disorders. We searched PubMed, PsycINFO, and Central until April 2024. We calculated standardized mean differences (SMDs) with 95% confidence intervals (CIs) from both intention-to-treat (ITT) and per-protocol (PP) data for...

DOI: 10.3389/fpsyt.2025.1616996 (opens in new tab) Full text (opens in new tab) Pranayama Complementary medicine Integrative medicine Mental disorders +2

Mindfulness cognitive-based therapy combined with metaphor therapy can improve problematic social media use.

Frontiers in Psychiatry 2025 Weirui Xiong, Lu Yu, Jinhui Chai

Problematic Social Media Use (PSMU) refers to an individual's long-term, high-intensity use of social media. Although this behavior is not pathological, it has a negative impact on the physical and mental health of individuals. In the past, intervention methods used for PSMU often controlled behavior to reduce the usage time of individual social media platforms. However, because psychological...

DOI: 10.3389/fpsyt.2025.1503049 (opens in new tab) Full text (opens in new tab) Meditation Metaphor therapy Mindfulness-based cognitive therapy Social media

Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use

Frontiers in Psychiatry December 6, 2024 Jonathan Brett, Elizabeth Knock, Kathy Watson et al. 7 citations

Methamphetamine (MA) dependence leads to severe physical and psychological issues. Current treatments, including psychosocial therapies and residential rehabilitation, face limitations such as high relapse rates, cost, and accessibility issues. As a result, there is an urgent need for novel approaches to treat MA dependence that are effective, affordable, and accessible to patients. Psilocybin,...

DOI: 10.3389/fpsyt.2024.1490907 (opens in new tab) Psilocybin Methamphetamine Hallucinogen Psychotherapist +1

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics.

Frontiers in Psychiatry November 6, 2024 Cristiano Chaves, Rafael G. Dos Santos, Serdar Dursun et al. 11 citations

The "wine of jurema", used in ancient Brazilian shamanic rituals, is rich in N,N-dimethyltryptamine (DMT), a naturally occurring tryptamine like serotonin and melatonin. Widely found in plants and animals, DMT is the main component of some botanical tisanes used for centuries as a channel of communication with the otherworld (1, 2). Despite being classified as a "classical psychedelic” (2-4),...

DOI: 10.3389/fpsyt.2024.1485337 (opens in new tab) Full text (opens in new tab) Psychedelics Mental health treatment Pharmacology Therapeutic research

A narrative exploration of psilocybin’s potential in mental health

Frontiers in Psychiatry October 30, 2024 Jisu Park, Taejung Kim, Han-Tsung Min et al. 4 citations

Psilocybin, a psychoactive substance, has recently garnered attention for its high therapeutic potential in psychiatry. In this study, we investigated the multifaceted aspects of psilocybin, highlighting its chemical properties, mechanisms of action, and burgeoning role in psychiatric treatment. Furthermore, we examined the clinical applications and potential therapeutic benefits of psilocybin...

DOI: 10.3389/fpsyt.2024.1429373 (opens in new tab) Psilocybin Hallucinogen Mental health Psychotherapist +2

Bad dream, nightmares and psychopathology: a systematic review

Frontiers in Psychiatry October 8, 2024 Julie Faccini, Jonathan Del‐Monte 7 citations

Objective: Bad dreams and nightmares can have a strong psychological impact. However, although the scientific literature points in the direction of an established association between nightmares and psychopathology, many of the studies investigating these links have been carried out on a general population. This systematic literature review aimed to identify studies that have used a sample from...

Close, yet so far away: a phenomenology of the praecox feeling in the diagnosis of schizophrenia as intercorporeal alienness

Frontiers in Psychiatry October 2, 2024 Iván Vial, Marcin Moskalewicz, Anastazja Szuła et al.

Debates concerning the reliability and validity of operationalized criteria and diagnostic tools have surrounded the issue of schizophrenia diagnosis and clinical decision-making related to the disorder. The notion of the praecox feeling (PF) has played a prominent role in the discussions as an example of the possibility of a rapid and potentially valid diagnosis based solely on “intuition” or...

Psilocybin for major depressive disorder: a systematic review of randomized controlled studies

Frontiers in Psychiatry September 23, 2024 Zhan-Ming Shi, Yu-Ping Ning, Xin-Hu Yang et al. 21 citations

Objectives The purpose of this systematic review of randomized controlled trials (RCTs) was to evaluate the effectiveness, safety, and tolerability of psilocybin in adult patients with major depressive disorder (MDD). Methods A systematic search (up to September 14, 2023) was conducted for RCTs that examined the efficacy, safety, and tolerability of psilocybin in physically healthy adult...

Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders – volume II

Frontiers in Psychiatry August 30, 2024 Glenn Hartelius, Sherry-Anne Muscat, Lucie Bartova

protocols are designed to integrate and harness the full range of ketamine's intrinsic properties, ketamine therapies can realize their full potentials [3], possibly leading to improved outcomes in broader patient populations. Our first paper, "The Montreal model: An integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression," takes this path toward...

The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis

Frontiers in Psychiatry August 13, 2024 Mu-Hong Chen, Shu-Li Cheng, Yu-Chen Kao et al. 8 citations

Objective Psilocybin-assisted therapy has shown promising efficacy on clinical depressive symptoms. However, diverse psychological support or psychotherapy was performed with psilocybin treatment. This study aimed to explore the association of psychological protocols with the efficacy of psilocybin-assisted therapy for depressive symptoms. Method Five major databases were systemic searched for...

DOI: 10.3389/fpsyt.2024.1439347 (opens in new tab) Psychedelic therapy Psychedelic-assisted treatment Mental health therapy Mood disorder treatment +4

Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report

Frontiers in Psychiatry July 16, 2024 André Do, Vanessa Michaud, Jean-François Stephan et al. 3 citations

Psilocybin has reemerged as a promising treatment for difficult-to-treat depression (DTD). Although there is limited evidence regarding interactions between psilocybin and other psychotropic drugs, clinical trials require that patients discontinue their antidepressants before study entry to isolate the benefits of psilocybin and to minimize the risk of adverse events. We present the first case...

Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension

Frontiers in Psychiatry June 24, 2024 Grant Jones, Jocelyn A. Ricard, Matthew K. Nock 5 citations

Background Hypertension is a major source of morbidity and mortality worldwide, particularly for racial and ethnic minorities who face higher rates of hypertension and worse health-related outcomes. Recent research has reported on protective associations between classic psychedelics and hypertension; however, there is a need to explore how race and ethnicity may moderate such associations....

DOI: 10.3389/fpsyt.2024.1169686 (opens in new tab) Nsduh Race Drug epidemiology Psilocybin research +3

Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder

Frontiers in Psychiatry June 11, 2024 Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska et al. 12 citations

Resistance to traditional treatment methods is still a major obstacle in modern psychiatry. As a result, several studies are currently being conducted to find effective alternatives to traditional therapies. One of these alternatives is psilocybin, a psychedelic substance that has been tested in clinical trials as an adjunct to psychotherapy. These studies focus on patients with major...